jueves, 18 de febrero de 2010

Es patente que las patentes...estan caducas (o próximas a...) (II)


Big Patent Expirations of 2010


2010 will still see patent expirations of some of the industry's blockbuster drugs. Teva, Apotex, Mylanand a slew of other generic drugmakers will have a chance to put a dent in the sales of a number of brand meds this year--including Flomax and Aricept. Lipitor, whose basic patent expires this year, doesn't face competition until 2011 because of Pfizer's deal with Ranbaxy, the first-filer. It's still included in the following list, which has a number of top-selling drugs.
Our 2010 patent expiration list also includes drugs whose patent actually expires, but managed to get a six-month extension due to pediatric exclusivity.



Ver

Ver anterior...

No hay comentarios: